Brett Sandercock

Chief Financial Officer · ResMed

Brett Sandercock (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in ResMed Inc. (RMD). The largest single filing was $257K of RMD (1,000 sh × $257.03, as filed), executed Feb 2. Data as of Nov 7 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.2M

shares × price, as filed

Last traded

Apr 1

Filed Apr 3

Median ADV $323.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

RMD

ResMed Inc. RMD · 0 buys · 18 sells 18 filings

Recent filings

RMDSALE ResMed Inc. View filing → $224K
1,000 sh × $224.31
Exec Apr 1
Filed Apr 3 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $254K
1,000 sh × $254.30
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $257K
1,000 sh × $257.03
Exec Feb 2
Filed Feb 3 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $242K
1,000 sh × $241.75
Exec Jan 2
Filed Jan 5 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $244K
1,000 sh × $244.16
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $743K
3,000 sh × $247.54
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $823K
3,000 sh × $274.36
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $812K
3,000 sh × $270.77
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET More filings →